Pre-clinical Data Supports Synlogic's Synthetic Biotic as a Potential Treatment for Phenylketonuria

Pre-clinical Data Supports Synlogic's Synthetic Biotic as a Potential Treatment for Phenylketonuria

Submitted by admin on August 14, 2018 - 12:09am
Source: 
CP Wire
News Tags: 
Synlogic
SYNB1618
microbiome
PKU
Headline: 
Pre-clinical Data Supports Synlogic's Synthetic Biotic as a Potential Treatment for Phenylketonuria
snippet: 

Synlogic, Inc., (Nasdaq: SYBX) announced on 8/13/18 the publication of data from preclinical studies of SYNB1618, the Company’s Synthetic Biotic development program targeting PKU,

Do Not Allow Advertisers to Use My Personal information